Digna Biotech, S.L.-Product Pipeline Review-2015

Digna Biotech, S.L.-Product Pipeline Review-2015

  • Products Id :- GMDHC06789CDB
  • |
  • Pages: 44
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Digna Biotech, S.L.-Product Pipeline Review-2015


Global Markets Direct's, 'Digna Biotech, S.L.-Product Pipeline Review-2015', provides an overview of the Digna Biotech, S.L.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Digna Biotech, S.L.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Digna Biotech, S.L. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Digna Biotech, S.L.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Digna Biotech, S.L.'s pipeline products

Reasons To Buy

Evaluate Digna Biotech, S.L.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Digna Biotech, S.L. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Digna Biotech, S.L.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Digna Biotech, S.L. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Digna Biotech, S.L.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Digna Biotech, S.L. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Digna Biotech, S.L. Snapshot 5

Digna Biotech, S.L. Overview 5

Key Information 5

Key Facts 5

Digna Biotech, S.L.-Research and Development Overview 6

Key Therapeutic Areas 6

Digna Biotech, S.L.-Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products-Monotherapy 11

Pipeline Products-Partnered Products 12

Partnered Products/Combination Treatment Modalities 13

Digna Biotech, S.L.-Pipeline Products Glance 14

Digna Biotech, S.L.-Clinical Stage Pipeline Products 14

Phase II Products/Combination Treatment Modalities 14

Phase I Products/Combination Treatment Modalities 15

Digna Biotech, S.L.-Early Stage Pipeline Products 16

Preclinical Products/Combination Treatment Modalities 16

Discovery Products/Combination Treatment Modalities 17

Digna Biotech, S.L.-Drug Profiles 18

cardiotrophin-1 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

disitertide 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Interferon Alfa-5 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

DB-017 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

DB-02901 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

DB-036 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

DB-039 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

DB-055 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

methylthioadenosine 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

oncostatin M 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

P-17 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

DB-027 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

Digna Biotech, S.L.-Pipeline Analysis 34

Digna Biotech, S.L.-Pipeline Products by Target 34

Digna Biotech, S.L.-Pipeline Products by Route of Administration 36

Digna Biotech, S.L.-Pipeline Products by Molecule Type 37

Digna Biotech, S.L.-Pipeline Products by Mechanism of Action 38

Digna Biotech, S.L.-Recent Pipeline Updates 40

Digna Biotech, S.L.-Dormant Projects 41

Digna Biotech, S.L.-Locations And Subsidiaries 42

Head Office 42

Other Locations & Subsidiaries 42

Appendix 43

Methodology 43

Coverage 43

Secondary Research 43

Primary Research 43

Expert Panel Validation 43

Contact Us 43

Disclaimer 44

List of Tables

Digna Biotech, S.L., Key Information 5

Digna Biotech, S.L., Key Facts 5

Digna Biotech, S.L.-Pipeline by Indication, 2015 8

Digna Biotech, S.L.-Pipeline by Stage of Development, 2015 10

Digna Biotech, S.L.-Monotherapy Products in Pipeline, 2015 11

Digna Biotech, S.L.-Partnered Products in Pipeline, 2015 12

Digna Biotech, S.L.-Partnered Products/ Combination Treatment Modalities, 2015 13

Digna Biotech, S.L.-Phase II, 2015 14

Digna Biotech, S.L.-Phase I, 2015 15

Digna Biotech, S.L.-Preclinical, 2015 16

Digna Biotech, S.L.-Discovery, 2015 17

Digna Biotech, S.L.-Pipeline by Target, 2015 35

Digna Biotech, S.L.-Pipeline by Route of Administration, 2015 36

Digna Biotech, S.L.-Pipeline by Molecule Type, 2015 37

Digna Biotech, S.L.-Pipeline Products by Mechanism of Action, 2015 39

Digna Biotech, S.L.-Recent Pipeline Updates, 2015 40

Digna Biotech, S.L.-Dormant Developmental Projects,2015 41

Digna Biotech, S.L., Other Locations 42

Digna Biotech, S.L., Subsidiaries 42

List of Figures

Digna Biotech, S.L.-Pipeline by Top 10 Indication, 2015 7

Digna Biotech, S.L.-Pipeline by Stage of Development, 2015 10

Digna Biotech, S.L.-Monotherapy Products in Pipeline, 2015 11

Digna Biotech, S.L.-Pipeline by Top 10 Target, 2015 34

Digna Biotech, S.L.-Pipeline by Top 10 Route of Administration, 2015 36

Digna Biotech, S.L.-Pipeline by Top 10 Molecule Type, 2015 37

Digna Biotech, S.L.-Pipeline Products by Top 10 Mechanism of Action, 2015 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Current R&D Portfolio of Digna Biotech, S.L.; Digna Biotech, S.L. - Key Therapeutics; Digna Biotech, S.L. - Pipeline Overview and Promising Molecules; Digna Biotech, S.L. - News; Digna Biotech, S.L. - Latest Updates; Digna Biotech, S.L. - Pipeline; Digna Biotech, S.L. - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 102450
Site License
USD 3000 INR 204900
Corporate User License
USD 4500 INR 307350



Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com